David C. Habiger
David C. Habiger's purchase track record
How the stock did after each of David C. Habiger's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/3/2026 | BSX | $157K | pending | pending | — |
| 5/19/2026 | BSX | $251K | -11.2% | pending | — |
| 3/12/2025 | RDDT | $199K | -12.0% | +98.2% | +16.7% |
| 8/21/2024 | XPER | $100K | -0.1% | +3.2% | +9.3% |
| 3/25/2024 | RDDT | $102K | -5.5% | +8.7% | +9.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
EnerSys Q2 Recap and Data Center Focus. Recent coverage benchmarks EnerSys' Q2 performance against renewable energy peers and highlights its exposure to data centers and defense. The stock is also mentioned in lists of value stocks and industrial peers, though it has been falling alongside other companies in the sector. These articles provide context on the company's current market position and sector trends.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Boston Scientific (BSX) Faces Catheter Recall Amid Valuation Debate. Boston Scientific announced a recall of 262,686 catheters because of a life‑threatening tip failure risk. The recall adds pressure as analysts note the company needs clear evidence of its turnaround to justify a better valuation. Truist Securities kept its rating but cut its price target to $51, reflecting a more cautious view. The stock has still moved higher than the broader market, indicating mixed investor reactions.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
BTIG keeps buy rating on Liftoff Mobile, cuts target to $27. BTIG has kept its buy rating for Liftoff Mobile but reduced its target price to $27. The new target sits below the current average analyst estimate of $33.40 and near the lower end of the 52‑week range. The stock is trading above its $18.38 support level and has an RSI of 40.4, indicating it is not yet overbought.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Xperi Subsidiary TiVo Launches Unified TV Data Product. TiVo Ads, a subsidiary of Xperi, has introduced an enhanced U.S. TV viewership data offering that combines set-top box and addressable connected TV data into a single feed. This move aims to streamline data access for advertisers using the company's technology. The stock is currently trading near its 52-week low, with technical indicators showing it is testing a key support level.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Adeia renews IP license agreement with Spectrum. Adeia announced that it has renewed its intellectual property license agreement with Spectrum. The renewal extends the existing collaboration and may support ongoing revenue streams. The company continues to rely on this partnership as part of its business model.
Transaction History
| RDDT | ▲ Buy | Grant | 284 | $0 | 10/5/2026 | View on chart |
| ENS | ▲ Buy | Grant | 8 | $0 | 10/2/2026 | View on chart |
| ENS | ▲ Buy | Grant | 3 | $0 | 10/2/2026 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 10/2/2026 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 10/2/2026 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 10/2/2026 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 10/2/2026 | View on chart |
| ENS | ▲ Buy | Grant | 982 | $0 | 8/14/2026 | View on chart |
| BSX | ▲ Buy | Open Market | 2,100 | $100K | 8/5/2026 | View on chart |
| BSX | ▲ Buy | Open Market | 140 | $7K | 8/4/2026 | View on chart |
| LFTO | ▲ Buy | Grant | 9,212 | $235K | 8/4/2026 | View on chart |
| BSX | ▲ Buy | Open Market | 1,042 | $50K | 8/3/2026 | View on chart |
| ENS | ▲ Buy | Grant | 143 | $28K | 7/16/2026 | View on chart |
| ENS | ▲ Buy | Grant | 28 | $0 | 7/16/2026 | View on chart |
| RDDT | ▲ Buy | Grant | 283 | $0 | 7/5/2026 | View on chart |
| ENS | ▲ Buy | Grant | 5 | $0 | 7/2/2026 | View on chart |
| ENS | ▲ Buy | Grant | 2 | $0 | 7/2/2026 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 7/2/2026 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 7/2/2026 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 7/2/2026 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 7/2/2026 | View on chart |
| RDDT | ▲ Buy | Grant | 1,714 | $0 | 6/8/2026 | View on chart |
| BSX | ▲ Buy | Open Market | 2,250 | $126K | 5/20/2026 | View on chart |
| BSX | ▲ Buy | Open Market | 2,200 | $125K | 5/19/2026 | View on chart |
| BSX | ▲ Buy | Grant | 3,800 | $0 | 5/7/2026 | View on chart |
| XPER | ▲ Buy | Grant | 29,320 | $0 | 4/17/2026 | View on chart |
| ENS | ▲ Buy | Grant | 28 | $0 | 4/13/2026 | View on chart |
| ENS | ▲ Buy | Grant | 143 | $28K | 4/13/2026 | View on chart |
| RDDT | ▲ Buy | Grant | 278 | $0 | 4/5/2026 | View on chart |
| ENS | ▲ Buy | Grant | 6 | $0 | 3/27/2026 | View on chart |
| ENS | ▲ Buy | Grant | 3 | $0 | 3/27/2026 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 3/27/2026 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 3/27/2026 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 3/27/2026 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 3/27/2026 | View on chart |
| ENS | ▲ Buy | Grant | 167 | $28K | 1/15/2026 | View on chart |
| ENS | ▲ Buy | Grant | 33 | $0 | 1/15/2026 | View on chart |
| RDDT | ▲ Buy | Grant | 217 | $0 | 1/5/2026 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 12/26/2025 | View on chart |
| ENS | ▲ Buy | Grant | 7 | $0 | 12/26/2025 | View on chart |
| ENS | ▲ Buy | Grant | 2 | $0 | 12/26/2025 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 12/26/2025 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 12/26/2025 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 12/26/2025 | View on chart |
| ENS | ▲ Buy | Grant | 218 | $27K | 10/16/2025 | View on chart |
| ENS | ▲ Buy | Grant | 43 | $0 | 10/16/2025 | View on chart |
| RDDT | ▲ Buy | Grant | 218 | $0 | 10/5/2025 | View on chart |
| ENS | ▲ Buy | Grant | 10 | $0 | 9/26/2025 | View on chart |
| ENS | ▲ Buy | Grant | 3 | $0 | 9/26/2025 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 9/26/2025 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 9/26/2025 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 9/26/2025 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 9/26/2025 | View on chart |
| ENS | ▲ Buy | Grant | 2,088 | $0 | 8/8/2025 | View on chart |
| ENS | ▲ Buy | Grant | 285 | $26K | 7/17/2025 | View on chart |
| ENS | ▲ Buy | Grant | 57 | $0 | 7/17/2025 | View on chart |
| RDDT | ▲ Buy | Grant | 395 | $0 | 7/5/2025 | View on chart |
| ENS | ▲ Buy | Grant | 6 | $0 | 6/27/2025 | View on chart |
| ENS | ▲ Buy | Grant | 2 | $0 | 6/27/2025 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 6/27/2025 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 6/27/2025 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 6/27/2025 | View on chart |
| RDDT | ▲ Buy | Grant | 2,285 | $0 | 6/9/2025 | View on chart |
| BSX | ▲ Buy | Grant | 2,081 | $0 | 5/8/2025 | View on chart |
| XPER | ▲ Buy | Grant | 25,815 | $0 | 4/25/2025 | View on chart |
| ENS | ▲ Buy | Grant | 333 | $27K | 4/10/2025 | View on chart |
| ENS | ▲ Buy | Grant | 67 | $0 | 4/10/2025 | View on chart |
| RDDT | ▲ Buy | Grant | 286 | $0 | 4/5/2025 | View on chart |
| ENS | ▲ Buy | Grant | 5 | $0 | 3/28/2025 | View on chart |
| ENS | ▲ Buy | Grant | 1 | $0 | 3/28/2025 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 3/28/2025 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 3/28/2025 | View on chart |
| RDDT | ▲ Buy | Open Market | 780 | $98K | 3/13/2025 | View on chart |
| RDDT | ▲ Buy | Open Market | 387 | $51K | 3/12/2025 | View on chart |
| RDDT | ▲ Buy | Open Market | 387 | $50K | 3/12/2025 | View on chart |
| ENS | ▲ Buy | Grant | 301 | $27K | 1/10/2025 | View on chart |
| ENS | ▲ Buy | Grant | 60 | $0 | 1/10/2025 | View on chart |
| ENS | ▲ Buy | Grant | 5 | $0 | 12/27/2024 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 12/27/2024 | View on chart |
| ENS | ▲ Buy | Grant | 0 | $0 | 12/27/2024 | View on chart |
| ENS | ▲ Buy | Grant | 143 | $15K | 10/18/2024 | View on chart |
| ENS | ▲ Buy | Grant | 29 | $0 | 10/18/2024 | View on chart |
| ENS | ▲ Buy | Grant | 5 | $0 | 9/30/2024 | View on chart |
| XPER | ▲ Buy | Open Market | 5,775 | $50K | 8/22/2024 | View on chart |
| XPER | ▲ Buy | Open Market | 5,750 | $50K | 8/21/2024 | View on chart |
| ENS | ▲ Buy | Grant | 2,026 | $0 | 8/9/2024 | View on chart |
| BSX | ▲ Buy | Grant | 1,252 | $0 | 8/1/2024 | View on chart |
| BSX | ▲ Buy | Grant | 2,155 | $0 | 8/1/2024 | View on chart |
| XPER | ▲ Buy | Grant | 21,739 | $0 | 5/29/2024 | View on chart |
| RDDT | ▲ Buy | Grant | 5,128 | $0 | 5/20/2024 | View on chart |
| RDDT | ▲ Buy | Open Market | 3,000 | $102K | 3/25/2024 | View on chart |
| XPER | ▲ Buy | Grant | 19,978 | $0 | 4/27/2023 | View on chart |
| XPER | ▲ Buy | Grant | 4,872 | — | 10/1/2022 | View on chart |
| ADEA | ▲ Buy | Grant | 12,179 | $12 | 4/29/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Jim Cramer Calls Reddit Stock Inexpensive Amid Recent Volatility
Jim Cramer recently described Reddit as inexpensive compared to other tech names, a view that follows a day where the stock jumped 7%. This positive commentary comes after the stock recently underperformed the broader market, suggesting a shift in sentiment. With the stock trading near its 200-day moving average, analysts are watching if this valuation appeal can drive further momentum.
Jim Cramer Calls Reddit Stock Inexpensive Amid Recent Volatility. Jim Cramer recently described Reddit as inexpensive compared to other tech names, a view that follows a day where the stock jumped 7%. This positive commentary comes after the stock recently underperformed the broader market, suggesting a shift in sentiment. With the stock trading near its 200-day moving average, analysts are watching if this valuation appeal can drive further momentum.